Glac Biotech Wins Double Honors at the iSEE Global Innovation Awards

Lactobacillus plantarum PL-02 Sets a New Benchmark for Functional Probiotics

Glac Biotech Achieves Another Milestone: Probiotic Strain CP-9 Receives U.S. FDA GRAS Certification

2025.08.07 Taiwan’s First GRAS-Certified Probiotic — Glac Biotech’s MP108 Achieves Historic U.S. FDA Recognition

2025.7.9 Glac Biotech Donates Probiotics to Support Vulnerable Communities in Changhua

2025.1.10 Totipro® Wins National Innovation Awards — Redefining the Future of Postbiotics

2024.9.5 Glac Biotech Brings Hope to Guangfu Elementary — A Story of Warmth in the Hills of Nantou

2024.5.31 Glac Biotech’s Probiotic Business Set to Break NT$500 Million in Revenue — A Story of Growth, Strategy, and Gl

2024.12.17 Glac Biotech × Public Good — Supporting Whole-Person Education and Building Dreams for the Next Generation

2024.7.23 Glac Biotech Unveils Next-Generation Probiotic Technology and Brain Health Innovations

2024.4.2 Glac Biotech’s Probiotic Strains F-1 & CP-9 — The Secret Engine Powering Global OEM Success

2023.9.28 Glac Biotech’s Totipro® PE0401 Makes History — First Postbiotic Ever to Win a NutraIngredients Award

2023.12.28 Over 90% Global Reorder Rate — Glac Biotech Becomes the Dark Horse of the Health Ingredient Supply Chain, Poi